Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$5.59
-1.2%
$5.96
$4.49
$9.94
$321.65M1.7877,919 shs14,101 shs
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$0.58
+15.9%
$0.56
$0.38
$1.60
N/A-0.198,781 shs11,248 shs
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$12.37
+4.1%
$13.55
$5.65
$17.16
$2.65B0.914.65 million shs2.36 million shs
LifeMD, Inc. stock logo
LFMD
LifeMD
$10.91
+9.1%
$9.06
$1.40
$12.01
$440.44M1.43820,904 shs982,613 shs
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$1.18
+4.4%
$1.61
$0.33
$2.66
$87.69M0.68125,766 shs51,927 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-0.70%+7.81%-1.91%-30.89%+13.20%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-9.05%-20.60%+10.79%-45.88%-64.52%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-0.17%-10.14%-27.25%+35.69%+1.71%
LifeMD, Inc. stock logo
LFMD
LifeMD
+3.09%+4.06%-10.23%+62.34%+488.24%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-5.04%-5.04%-17.52%-46.45%+103.97%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
2.3076 of 5 stars
3.31.00.00.00.93.31.9
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
3.372 of 5 stars
3.32.00.00.02.44.21.9
LifeMD, Inc. stock logo
LFMD
LifeMD
0.068 of 5 stars
1.52.00.00.00.00.80.0
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
1.7189 of 5 stars
3.53.00.00.00.71.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
2.50
Moderate Buy$8.0043.11% Upside
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.62
Moderate Buy$14.8520.02% Upside
LifeMD, Inc. stock logo
LFMD
LifeMD
3.00
Buy$10.40-4.67% Downside
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
3.00
Buy$2.2590.68% Upside

Current Analyst Ratings

Latest HIMS, AIRS, TOI, LFMD, and CCM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/23/2024
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
4/16/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$17.00 ➝ $15.00
4/10/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$20.00
4/10/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$20.00
3/15/2024
LifeMD, Inc. stock logo
LFMD
LifeMD
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$11.00 ➝ $13.00
2/28/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Imperial Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeIn-Line ➝ Outperform$16.00
2/27/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $16.00
2/27/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $17.00
2/27/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$9.00 ➝ $11.00
2/27/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$10.00 ➝ $13.00
2/26/2024
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$195.92M1.64$0.21 per share26.92$1.46 per share3.83
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$68.45MN/AN/AN/A$6.73 per shareN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$872M3.04N/AN/A$1.61 per share7.68
LifeMD, Inc. stock logo
LFMD
LifeMD
$152.55M2.89N/AN/A$0.15 per share72.73
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
$324.24M0.27N/AN/A$0.77 per share1.53

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
-$4.48M-$0.08N/A18.03N/A-2.29%1.74%0.68%5/10/2024 (Estimated)
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-$70.99MN/A0.00N/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$23.55M-$0.11N/A53.78N/A-2.70%-7.21%-5.81%5/6/2024 (Confirmed)
LifeMD, Inc. stock logo
LFMD
LifeMD
-$20.60M-$0.70N/AN/AN/A-14.01%N/A-50.74%5/10/2024 (Estimated)
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$83.07M-$0.92N/AN/AN/A-24.56%-80.46%-28.14%5/8/2024 (Estimated)

Latest HIMS, AIRS, TOI, LFMD, and CCM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.0160N/A-$0.0160N/AN/AN/A  
3/27/2024Q4 2023
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
-$0.11-$0.21-$0.10-$0.21$82.04 million$85.79 million
3/11/2024Q4 2023
LifeMD, Inc. stock logo
LFMD
LifeMD
-$0.14-$0.12+$0.02-$0.12$40.65 million$44.86 million
2/27/2024Q4 2023
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
$0.05-$0.06-$0.11-$0.04$47.83 million$47.61 million
2/26/2024Q4 2023
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-$0.02$0.01+$0.03$0.01$245.84 million$246.60 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
N/AN/AN/AN/AN/A
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
LifeMD, Inc. stock logo
LFMD
LifeMD
N/AN/AN/AN/AN/A
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
0.83
0.79
0.79
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/A
3.00
2.74
LifeMD, Inc. stock logo
LFMD
LifeMD
3.22
1.22
1.15
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
1.52
4.12
3.73

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
91.54%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/A
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
LifeMD, Inc. stock logo
LFMD
LifeMD
35.52%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
36.86%

Insider Ownership

CompanyInsider Ownership
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
78.30%
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
46.50%
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
31.63%
LifeMD, Inc. stock logo
LFMD
LifeMD
18.89%
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
13.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AirSculpt Technologies, Inc. stock logo
AIRS
AirSculpt Technologies
34657.54 million12.49 millionOptionable
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
918N/AN/ANot Optionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
1,046214.25 million146.48 millionOptionable
LifeMD, Inc. stock logo
LFMD
LifeMD
20740.37 million32.74 millionOptionable
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
80074.31 million64.58 millionNot Optionable

HIMS, AIRS, TOI, LFMD, and CCM Headlines

SourceHeadline
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference CallThe Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
finance.yahoo.com - April 23 at 8:41 AM
Kol docs-UK institute study to design training for breast cancer checkKol docs-UK institute study to design training for breast cancer check
timesofindia.indiatimes.com - April 21 at 8:49 PM
How each zodiac signs shows they are more than just friendsHow each zodiac signs shows they are more than just friends
msn.com - April 21 at 3:49 PM
AI Tool Predicts Responses to Cancer Therapy Using Info from Each Tumor CellAI Tool Predicts Responses to Cancer Therapy Using Info from Each Tumor Cell
labmanager.com - April 20 at 1:11 PM
AI tool predicts responses to cancer therapy using information from each cell of the tumorAI tool predicts responses to cancer therapy using information from each cell of the tumor
medicalxpress.com - April 18 at 1:41 PM
New trial shows immunotherapy post-surgery improves overall survival for kidney cancerNew trial shows immunotherapy post-surgery improves overall survival for kidney cancer
medicalxpress.com - April 18 at 8:40 AM
Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
msn.com - April 18 at 8:40 AM
Topicus.com Inc. Announces Release Date for First Quarter ResultsTopicus.com Inc. Announces Release Date for First Quarter Results
markets.businessinsider.com - April 18 at 3:39 AM
Florida system raises $93M for cancer instituteFlorida system raises $93M for cancer institute
beckershospitalreview.com - April 15 at 1:28 PM
Rheumatologists join oncology space to treat debilitating side effects without affecting cancer controlRheumatologists join oncology space to treat debilitating side effects without affecting cancer control
highlandcountypress.com - April 13 at 6:29 PM
Study Provides First Look at Oncologists’ Views on Ethical Implications of AI in Cancer CareStudy Provides First Look at Oncologists’ Views on Ethical Implications of AI in Cancer Care
cancerhealth.com - April 13 at 6:29 PM
Avinash Reddy confident of his hat-trick at Kadapa parliament despite onslaught unleashed by YS sistersAvinash Reddy confident of his hat-trick at Kadapa parliament despite onslaught unleashed by YS sisters
timesofindia.indiatimes.com - April 13 at 6:29 PM
Daily healthy habits to reduce cancer riskDaily healthy habits to reduce cancer risk
msn.com - April 10 at 8:21 AM
Jordan McInerney Appointed as Chief Development Officer of The Oncology InstituteJordan McInerney Appointed as Chief Development Officer of The Oncology Institute
finance.yahoo.com - April 8 at 10:07 AM
Kent Lake Capital LLC Buys 901,956 Shares of The Oncology Institute, Inc. (NASDAQ:TOI)Kent Lake Capital LLC Buys 901,956 Shares of The Oncology Institute, Inc. (NASDAQ:TOI)
marketbeat.com - April 6 at 7:36 PM
The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern CaliforniaThe Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
globenewswire.com - April 4 at 8:00 AM
Centre for early cancer detection is gifted £11mCentre for early cancer detection is gifted £11m
msn.com - April 4 at 1:03 AM
Deaths foretoldDeaths foretold
timesofindia.indiatimes.com - April 3 at 12:01 AM
Study finds AI empowers patients before and after seeing physicians for radiation oncology treatmentStudy finds AI empowers patients before and after seeing physicians for radiation oncology treatment
msn.com - April 2 at 7:01 PM
Man dies after 3 hospitals deny entry in DelhiMan dies after 3 hospitals deny entry in Delhi
msn.com - April 2 at 3:59 AM
Man Dies After 3 Hosps Deny EntryMan Dies After 3 Hosps Deny Entry
timesofindia.indiatimes.com - April 1 at 10:59 PM
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call TranscriptThe Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 1 at 5:58 PM
How an Indian-made cervical cancer vaccine can save 2 lakh livesHow an Indian-made cervical cancer vaccine can save 2 lakh lives
timesofindia.indiatimes.com - March 31 at 9:37 PM
Are we over-looking elderly loneliness?Are we over-looking elderly loneliness?
msn.com - March 30 at 3:33 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AirSculpt Technologies logo

AirSculpt Technologies

NASDAQ:AIRS
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
Concord Medical Services logo

Concord Medical Services

NYSE:CCM
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, head gamma knife system, and diagnostic imaging services. The company's other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Hims & Hers Health logo

Hims & Hers Health

NYSE:HIMS
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
LifeMD logo

LifeMD

NASDAQ:LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
Oncology Institute logo

Oncology Institute

NASDAQ:TOI
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.